title: Expression of fibroblast growth factor binding protein in head and neck cancer.
abstract: OBJECTIVE
  To characterize the expression of fibroblast growth factor binding protein (FGF-BP) messenger RNA (mRNA) in head and neck squamous cell carcinoma (HNSCC) and to study the association of FGF-BP with vascularity.
  
  
  METHODS
  The expression of FGF-BP mRNA in HNSCC was studied in 35 primary and 8 metastatic HNSCC specimens and 7 control tissues using in situ hybridization and reverse transcriptase-polymerase chain reaction (RT-PCR). Microvessels in tumor specimens were identified with endothelial cell markers (von Willebrand factor [vWF] and CD34-specific antibodies). Correlates between FGF-BP and microvessel counts were evaluated statistically.
  
  
  METHODS
  University of Minnesota Hospitals and Clinics.
  
  
  METHODS
  Forty-two surgically treated patients with HNSCC.
  
  
  METHODS
  The patients were routinely treated in the study hospitals and clinics.
  
  
  METHODS
  The expression of FGF-BP and angiogenesis in tumors were evaluated.
  
  
  RESULTS
  In situ hybridization and RT-PCR demonstrated that FGF-BP mRNA transcripts were expressed in 34 of 35 primary HNSCC specimens and 5 of 8 metastatic tumor specimens but not in adjacent control tissues. The microvessel counts in HNSCC specimens were closely related to the expression level of FGF-BP (P < .001).
  
  
  CONCLUSIONS
  The expression of FGF-BP is statistically linked to the angiogenesis of HNSCC, suggesting that FGF-BP participates in the angiogenesis of HNSCC.
authors.affiliation: Department of Otolaryngology, University of Minnesota School of Medicine, Minneapolis, MN 55455, USA.
authors.forename: Weimin
authors.initials: W
authors.lastname: Li
authors.forename: Chuan
authors.initials: C
authors.lastname: Wang
authors.forename: Steven K
authors.initials: SK
authors.lastname: Juhn
authors.forename: Frank G
authors.initials: FG
authors.lastname: Ondrey
authors.forename: Jizhen
authors.initials: J
authors.lastname: Lin
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000235:genetics / Q000378:metabolism*; D001707:Biopsy, Needle; D002294:Carcinoma, Squamous Cell / Q000235:genetics* / Q000473:pathology; D002352:Carrier Proteins / Q000235:genetics / Q000378:metabolism*; D016022:Case-Control Studies; D005260:Female; D005346:Fibroblast Growth Factors / Q000235:genetics / Q000378:metabolism; D015972:Gene Expression Regulation, Neoplastic; D006258:Head and Neck Neoplasms / Q000235:genetics* / Q000473:pathology; D006801:Humans; D007150:Immunohistochemistry; D017403:In Situ Hybridization; D008297:Male; D008565:Membrane Proteins; D055806:Microvessels / Q000473:pathology; D008875:Middle Aged; D009367:Neoplasm Staging; D011336:Probability; D011379:Prognosis; D012016:Reference Values; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012494:Sampling Studies; D012680:Sensitivity and Specificity
chemical_list: D014408:Biomarkers, Tumor; D002352:Carrier Proteins; C116274:FIBP protein, human; D008565:Membrane Proteins; D005346:Fibroblast Growth Factors